Piper Jaffray Starts Alder Biopharm (ALDR) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St muted after Fed Chair Warsh's speech; AI rally cools
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil drifts lower as Hormuz flows balance slow progress in Iran diplomacy
- Dollar climbs after Warsh comments, poised for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- BioNTech ends colorectal cancer mRNA therapy trial early
Alder BioPharma (ALDR) Tops Q3 EPS by 15c
October 27, 2016 4:16 PM EDTAlder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.70), $0.15 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
... More